Gregory E. Chittick

1.0k total citations
18 papers, 798 citations indexed

About

Gregory E. Chittick is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Gregory E. Chittick has authored 18 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 8 papers in Virology and 3 papers in Epidemiology. Recurrent topics in Gregory E. Chittick's work include HIV/AIDS drug development and treatment (13 papers), HIV Research and Treatment (8 papers) and HIV/AIDS Research and Interventions (4 papers). Gregory E. Chittick is often cited by papers focused on HIV/AIDS drug development and treatment (13 papers), HIV Research and Treatment (8 papers) and HIV/AIDS Research and Interventions (4 papers). Gregory E. Chittick collaborates with scholars based in United States, United Kingdom and France. Gregory E. Chittick's co-authors include James A. McDowell, Daniel S. Stein, Laurene H. Wang, Martin Blum, John Begley, Jian Zong, Ronald E. Polk, Brian M. Sadler, William T. Symonds and Yu Lou and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Hepatology and American Journal of Kidney Diseases.

In The Last Decade

Gregory E. Chittick

18 papers receiving 772 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Gregory E. Chittick 484 287 198 127 116 18 798
Rosa F. Yeh 348 0.7× 166 0.6× 135 0.7× 140 1.1× 105 0.9× 25 682
Agnes I. Veldkamp 697 1.4× 510 1.8× 185 0.9× 61 0.5× 140 1.2× 27 943
Ronald D’Amico 528 1.1× 364 1.3× 238 1.2× 51 0.4× 108 0.9× 70 942
Tsunefusa Hayashida 423 0.9× 277 1.0× 202 1.0× 83 0.7× 53 0.5× 31 655
Neil Buss 375 0.8× 252 0.9× 130 0.7× 61 0.5× 90 0.8× 17 655
Aurélie Fayet 408 0.8× 254 0.9× 58 0.3× 86 0.7× 111 1.0× 11 552
Becky Chandler 382 0.8× 218 0.8× 96 0.5× 330 2.6× 186 1.6× 16 659
Sheila Breidinger 466 1.0× 311 1.1× 79 0.4× 78 0.6× 140 1.2× 23 697
Jennifer E. Vela 931 1.9× 367 1.3× 296 1.5× 113 0.9× 109 0.9× 19 1.2k
Edmund Ho 355 0.7× 117 0.4× 352 1.8× 337 2.7× 219 1.9× 9 918

Countries citing papers authored by Gregory E. Chittick

Since Specialization
Citations

This map shows the geographic impact of Gregory E. Chittick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory E. Chittick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory E. Chittick more than expected).

Fields of papers citing papers by Gregory E. Chittick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory E. Chittick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory E. Chittick. The network helps show where Gregory E. Chittick may publish in the future.

Co-authorship network of co-authors of Gregory E. Chittick

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory E. Chittick. A scholar is included among the top collaborators of Gregory E. Chittick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory E. Chittick. Gregory E. Chittick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Grimley, Michael, Roy F. Chemaly, Janet A. Englund, et al.. (2017). Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial. Biology of Blood and Marrow Transplantation. 23(3). 512–521. 118 indexed citations
2.
Papanicolaou, Genovefa A., Yeon Joo Lee, James W. Young, et al.. (2015). Brincidofovir for Polyomavirus-Associated Nephropathy After Allogeneic Hematopoietic Stem Cell Transplantation. American Journal of Kidney Diseases. 65(5). 780–784. 44 indexed citations
3.
Florescu, Diana F., David F. Mercer, Michael Grimley, et al.. (2014). Brincidofovir (CMX001) for the Treatment of Serious or Life-Threatening Double-Stranded DNA Virus Infections in Patients Receiving Liver Transplant as Part of Multiorgan Transplantation.. Transplantation. 98. 662–662. 2 indexed citations
4.
Lopatin, Uri, Grushenka H.I. Wolfgang, Gregory E. Chittick, et al.. (2011). 737 A PHASE-I, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE ESCALATING ORAL DOSES OF GS-9620 IN HEALTHY SUBJECTS. Journal of Hepatology. 54. S296–S296. 6 indexed citations
5.
Chittick, Gregory E., et al.. (2008). Pharmacokinetics of emtricitabine/tenofovir disoproxil fumarate and tacrolimus at steady state when administered alone or in combination. International Journal of Clinical Pharmacology and Therapeutics. 46(12). 627–636. 6 indexed citations
6.
Zong, Jian, Gregory E. Chittick, Laurene H. Wang, et al.. (2007). Pharmacokinetic Evaluation of Emtricitabine in Combination With Other Nucleoside Antivirals in Healthy Volunteers. The Journal of Clinical Pharmacology. 47(7). 877–889. 23 indexed citations
7.
Blum, Martin, Gregory E. Chittick, John Begley, & Jian Zong. (2007). Steady‐State Pharmacokinetics of Emtricitabine and Tenofovir Disoproxil Fumarate Administered Alone and in Combination in Healthy Volunteers. The Journal of Clinical Pharmacology. 47(6). 751–759. 71 indexed citations
8.
Chittick, Gregory E., Jian Zong, Martin Blum, et al.. (2006). Pharmacokinetics of Tenofovir Disoproxil Fumarate and Ritonavir-Boosted Saquinavir Mesylate Administered Alone or in Combination at Steady State. Antimicrobial Agents and Chemotherapy. 50(4). 1304–1310. 40 indexed citations
9.
Wang, Laurene H., Andrew Wiznia, Mobeen H. Rathore, et al.. (2003). Pharmacokinetics and Safety of Single Oral Doses of Emtricitabine in Human Immunodeficiency Virus-Infected Children. Antimicrobial Agents and Chemotherapy. 48(1). 183–191. 35 indexed citations
10.
Sadler, Brian M., Gregory E. Chittick, Ronald E. Polk, et al.. (2001). Metabolic Disposition and Pharmacokinetics of [14C]‐Amprenavir, a Human Immunodeficiency Virus Type 1 (HIV‐1) Protease Inhibitor, Administered As a Single Oral Dose to Healthy Male Subjects. The Journal of Clinical Pharmacology. 41(4). 386–396. 16 indexed citations
11.
Polk, Ronald E., Donald F. Brophy, Debra S. Israel, et al.. (2001). Pharmacokinetic Interaction between Amprenavir and Rifabutin or Rifampin in Healthy Males. Antimicrobial Agents and Chemotherapy. 45(2). 502–508. 53 indexed citations
12.
McDowell, James A., et al.. (2000). Pharmacokinetic Interaction of Abacavir (1592U89) and Ethanol in Human Immunodeficiency Virus-Infected Adults. Antimicrobial Agents and Chemotherapy. 44(6). 1686–1690. 55 indexed citations
13.
Wang, Laurene H., Gregory E. Chittick, & James A. McDowell. (1999). Single-Dose Pharmacokinetics and Safety of Abacavir (1592U89), Zidovudine, and Lamivudine Administered Alone and in Combination in Adults with Human Immunodeficiency Virus Infection. Antimicrobial Agents and Chemotherapy. 43(7). 1708–1715. 58 indexed citations
14.
Chittick, Gregory E., Catherine Gillotin, James A. McDowell, et al.. (1999). Abacavir: Absolute Bioavailability, Bioequivalence of Three Oral Formulations, and Effect of Food. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(8). 932–942. 44 indexed citations
15.
Polk, Ronald E., Michael A. Crouch, Debra S. Israel, et al.. (1999). Pharmacokinetic Interaction between Ketoconazole and Amprenavir after Single Doses in Healthy Men. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(12). 1378–1384. 35 indexed citations
16.
17.
18.
Seaber, Emma J., N.T. On, Ruth Dixon, et al.. (1997). The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90). British Journal of Clinical Pharmacology. 43(6). 579–587. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosa F. Yeh Breakdown of academic impact, for papers by Agnes I. Veldkamp Breakdown of academic impact, for papers by Ronald D’Amico Breakdown of academic impact, for papers by Tsunefusa Hayashida Breakdown of academic impact, for papers by Neil Buss Breakdown of academic impact, for papers by Aurélie Fayet Breakdown of academic impact, for papers by Becky Chandler Breakdown of academic impact, for papers by Sheila Breidinger Breakdown of academic impact, for papers by Jennifer E. Vela Breakdown of academic impact, for papers by Edmund Ho
Rankless by CCL
2026